Abstract
Cone-beam computed tomography (CBCT) was developed in the early 80 s by the Biodynamics Research Unit at the Mayo Clinic for develo** “high temporal resolution and synchronous volume scanning” [1]. Over the past 40 years, CBCT has evolved in two directions: aided interventional radiology (IR) procedures and in oral/maxillofacial radiology [2]. These two streams were developed for two different reasons, in particular, in the set of interventional radiology procedures, for the possibility to supply unique planning and prognostic information and, concerning oral/maxillofacial radiology, for high-quality images, compact size, low cost, and low-ionizing radiation [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Robb RA. The dynamic spatial Reconstructor: an X-ray video-fluoroscopic CT scanner for dynamic volume imaging of moving organs. IEEE Trans Med Imaging. 1982;1(1):22–33.
Venkatesh E, Elluru SV. Cone beam computed tomography: basics and applications in dentistry. J Istanb Univ Fac Dent. 2017;51(3 Suppl 1):S102–21.
Scarfe WC, Farman AG. What is cone-beam CT and how does it work? Dent Clin N Am. 2008;52(4):707–30. v
Tognolini A, et al. C-arm computed tomography for hepatic interventions: a practical guide. J Vasc Interv Radiol. 2010;21(12):1817–23.
Yorkston J, Rowlands J. Flat panel detectors for digital radiography. 2000.
Tacher V, et al. How I do it: cone-beam CT during Transarterial chemoembolization for liver cancer. Radiology. 2015;274(2):320–34.
Lucatelli P, et al. Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer. Transl Gastroenterol Hepatol. 2017;2:83.
Shaw CC. Cone beam computed tomography. Taylor & Francis; 2014.
Floridi C, et al. C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med. 2014;119(7):521–32.
Grass M, et al. Three-dimensional reconstruction of high contrast objects using C-arm image intensifier projection data. Comput Med Imaging Graph. 1999;23(6):311–21.
Lin E, Alessio A. What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr. 2009;3(6):403–8.
Wang J, Fleischmann D. Improving spatial resolution at CT: development, benefits, and pitfalls. Radiology. 2018;289(1):261–2.
Miller DL, et al. Quality improvement guidelines for recording patient radiation dose in the medical record for fluoroscopically guided procedures. J Vasc Interv Radiol. 2012;23(1):11–8.
Suzuki S, et al. Evaluation of effective dose during abdominal three-dimensional imaging for three flat-panel-detector angiography systems. Cardiovasc Intervent Radiol. 2011;34(2):376–82.
Loffroy R, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology. 2013;266(2):636–48.
The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP, 2007. 37(2–4): p. 1–332.
Kothary N, et al. Imaging guidance with C-arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization. J Vasc Interv Radiol. 2011;22(11):1535–43.
Lee IJ, et al. Cone-beam CT hepatic arteriography in chemoembolization for hepatocellular carcinoma: angiographic image quality and its determining factors. J Vasc Interv Radiol. 2014;25(9):1369–79. quiz 1379-e1
Mitchell DG, et al. LI-RADS (liver imaging reporting and data system): summary, discussion, and consensus of the LI-RADS Management working group and future directions. Hepatology. 2015;61(3):1056–65.
Lee IJ, et al. Cone-beam computed tomography (CBCT) hepatic arteriography in chemoembolization for hepatocellular carcinoma: performance depicting tumors and tumor feeders. Cardiovasc Intervent Radiol. 2015;38(5):1218–30.
Ushijima Y, et al. Detecting hepatic nodules and identifying feeding arteries of hepatocellular carcinoma: efficacy of cone-beam computed tomography in transcatheter arterial chemoembolization. Hepatoma Res. 2016;2:231–6.
Pung L, et al. The role of cone-beam CT in Transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. J Vasc Interv Radiol. 2017;28(3):334–41.
Mikhail AS, et al. Map** drug dose distribution on CT images following Transarterial chemoembolization with radiopaque drug-eluting beads in a rabbit tumor model. Radiology. 2018;289(2):396–404.
Lucatelli P, et al. Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure. Eur J Radiol. 2020;124:108806.
Abdel Razek AAK, et al. Liver imaging reporting and data system version 2018: what radiologists need to know. J Comput Assist Tomogr. 2020;44(2):168–77.
EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
Lucatelli P, et al. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE. Radiol Med. 2019;124(12):1212–9.
Lucatelli P, et al. Are radiopaque beads a real advantage? Radiology. 2019;290(3):852.
Orlacchio A, et al. Role of cone-beam CT in the intraprocedural evaluation of chemoembolization of hepatocellular carcinoma. J Oncol. 2021;2021:8856998.
Iwazawa J, et al. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma. Am J Roentgenol. 2011;197(2):W337–42.
Suk Oh J, et al. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. J Vasc Interv Radiol. 2013;24(4):483–9.
Miyayama S, et al. Detection of hepatocellular carcinoma by CT during arterial portography using a cone-beam CT technology: comparison with conventional CTAP. Abdom Imaging. 2009;34(4):502–6.
Kim KA, et al. The efficacy of cone-beam CT-based liver perfusion map** to predict initial response of hepatocellular carcinoma to transarterial chemoembolization. J Vasc Interv Radiol. 2019;30(3):358–69.
Syha R, et al. Parenchymal blood volume assessed by C-arm-based computed tomography in immediate posttreatment evaluation of drug-eluting bead Transarterial chemoembolization in hepatocellular carcinoma. Investig Radiol. 2016;51(2):121–6.
Choi SY, et al. Usefulness of cone-beam ct-based liver perfusion map** for evaluating the response of hepatocellular carcinoma to conventional transarterial chemoembolization. J Clin Med. 2021;10:4.
Forner A, et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(01):061–74.
Vogel A, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2018;29(Supplement_4):iv238–55.
McVey JC, Sasaki K, Firl DJ. Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology. Hepat Oncol. 2020;7(3):HEP26.
Cornelis FH, et al. Hepatic arterial embolization using cone beam CT with tumor feeding vessel detection software: impact on hepatocellular carcinoma response. Cardiovasc Intervent Radiol. 2018;41(1):104–11.
Joo SM, et al. Optimized performance of flight plan during chemoembolization for hepatocellular carcinoma: importance of the proportion of segmented tumor area. Korean J Radiol. 2016;17(5):771–8.
Tamai T, et al. Reduction effect of the quantity of radiation exposure and contrast media by image support system in transarterial chemoembolization for the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2018;33(5):1115–22.
Cui Z, et al. A systematic review of automated feeder detection software for locoregional treatment of hepatic tumors. Diagn Interv Imaging. 2020;101(7):439–49.
Miyayama S, et al. Outcomes of patients with hepatocellular carcinoma treated with conventional Transarterial chemoembolization using guidance software. J Vasc Interv Radiol. 2019;30(1):10–8.
Chiaradia M, et al. Sensitivity and reproducibility of automated feeding artery detection software during Transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2018;29(3):425–31.
Yao X, et al. Dual-phase cone-beam CT-based navigation imaging significantly enhances tumor detectability and aids superselective transarterial chemoembolization of liver cancer. Acad Radiol. 2018;25(8):1031–7.
Soliman MM, et al. Use of virtual injection software to aid in microcatheter positioning during Transarterial chemoembolization. J Vasc Interv Radiol. 2019;30(10):1646–8.
Ortiz AK, et al. Injection simulation software identifies missed tumor-supplying vessel in a patient with residual disease after Transarterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2021;44(5):812–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
De Rubeis, G., Castiello, G., Giuliani, M.S., Riu, P.R., Fabiano, S., Cianni, R. (2023). CBCT and Software. In: Lucatelli, P. (eds) Transarterial Chemoembolization (TACE) . Springer, Cham. https://doi.org/10.1007/978-3-031-36261-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-36261-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36260-6
Online ISBN: 978-3-031-36261-3
eBook Packages: MedicineMedicine (R0)